Beyond ten-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
Background: Cholesterol guidelines typically prioritize primary prevention statin therapy based on 10-year risk of cardiovascular disease. The advent of generic pricing may justify expansion of statin eligibility. Moreover, 10-year risk may not be the optimal approach for statin prioritization. We e...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Lippincott, Williams & Wilkins
2022
|